about
Emerging local ablative therapies for unresectable perihilar cholangiocarinoma: Time for re-appraisal.Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma casesPreoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial.Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent ResectionPreoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainageExternal biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinomaDiagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis.Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic CancerStudy protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumoursAblation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.(99m)Tc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma.High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry.Nasal carriage of Staphylococcus aureus among surgeons and surgical residents: a nationwide prevalence study.Systematic review of transarterial embolization for hepatocellular adenomas.Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging LaparoscopyIn vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus.External Validation of the Estimation of Physiologic Ability and Surgical Stress (E-PASS) Risk Model to Predict Operative Risk in Perihilar Cholangiocarcinoma.Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters.The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma.Conditional survival in patients with unresectable perihilar cholangiocarcinoma.Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma.IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary Care Experience.Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.Importance of Preoperative Optimization in Resection of Perihilar Cholangiocarcinoma.East or West, Who Grades Liver Failure After Liver Resection for Perihilar Cholangiocarcinoma Best?Preoperative Sarcopenia Negatively Impacts Postoperative Outcomes Following Major Hepatectomy with Extrahepatic Bile Duct ResectionThe impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature
P50
Q33632997-BA4DAF62-7549-46A8-B5B6-E56782A077FEQ33732027-514A5116-5188-4288-A31E-B47D6987F3CFQ34383286-BC8CB57E-966C-4A39-AD99-75B0D7F7D706Q35607238-2B465752-5204-43C1-AE95-D4575455B199Q36391818-EB3831AC-49CF-40CA-BD78-2343F56A8894Q36529570-CF4E1D8E-160E-42DA-B775-4B7366B4FC5FQ36556087-A7D6E5FD-8CE5-46FF-BCE5-59D923AE5D9DQ36747389-9A844FDC-AA79-4234-A83A-DDB4F83C78E9Q36747444-D3E57C4C-F49D-4C8F-837E-2E09B0A52C02Q37227475-368F3DE5-35F5-4397-833D-6E2259500594Q37528758-C4E40CA8-04D3-46E2-BB1F-4EBD64B34BFFQ38375735-616F3039-1213-4FC7-BC53-20B2F700A935Q38597196-4023C7AA-BC12-41BB-8988-10463A4A8A3FQ38661180-C8A3CF01-C765-4555-98E9-722F0143183EQ38661231-D7B2A192-BCC9-47EA-A76D-6A7BD65DC5B1Q38747959-FB0F175F-42DE-4888-9C81-FF6DF4C75CF5Q39023303-54DACFA9-6AC3-4005-B09C-98C701C5CB7AQ39314901-63725758-1711-4103-8056-5194E692A722Q39431117-94EC60CD-E8CF-4ABB-80F7-64199153F410Q40242582-23288073-3D86-4009-92E3-69E4F4015EFFQ40600473-387D8C70-99C8-4FAB-80F3-52CEF51BC7CDQ47270143-CE6EC223-8324-406A-A7D3-BA55ED4C60F2Q49357127-FB2DB97B-12C4-4E7B-AFFD-140DEE00598DQ49667131-B76537C7-4659-483D-A1A6-1C66619F8C7DQ50517385-D1ABB4BC-DDC9-4372-837C-B8F9133AB9C8Q50630807-9DD68A02-3A9C-491A-BDCF-D2FEEDB65DF2Q52651191-13069B8A-462B-4AF8-AC44-7E38D90507B9Q53263862-53620E8E-3208-4C8B-B640-6361C039E707Q53966127-0730A25E-EA06-4C99-92B5-D65F6749F501Q57132265-64E8437E-F51E-40A0-AE14-EB12048048F6Q57142962-A72A42CF-B5C1-4847-8403-0119B0FB2E91Q86529577-B4609563-8FEB-45D2-81D6-6C0203D654EA
P50
description
investigador
@es
researcher
@en
name
Robert J S Coelen
@en
type
label
Robert J S Coelen
@en
prefLabel
Robert J S Coelen
@en
P31
P496
0000-0003-4100-8239